[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.147.241.171. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 1990

Antitransferrin Receptor Immunotoxin Inhibits Proliferating Human Retinal Pigment Epithelial Cells

Author Affiliations

From the Department of Ophthalmology, Duke University Eye Center, Durham, NC (Drs Jaffe and Fulcher and Ms Earnest); the Department of Ophthalmology, University of California, San Francisco (Dr Lui); and Cetus Corporation, Emeryville, Calif (Dr Houston).

Arch Ophthalmol. 1990;108(8):1163-1168. doi:10.1001/archopht.1990.01070100119046
Abstract

• Cultured human retinal pigment epithelial cells were exposed to an immunotoxin composed of a monoclonal antibody, 454A12, directed against transferrin receptors conjugated to a toxin, recombinant ricin A chain. Exposure of proliferating human retinal pigment epithelial cells to the immunotoxin (0.1 to 10 000 ng/mL) caused a statistically significant (P<.0001) decrease in the number of cells. This inhibitory effect was induced after an exposure to the immunotoxin as short as 5 minutes and was maximal after 24 hours of exposure. The diminution in cell number was dose dependent over the range from 0.1 to 100 ng/mL. Monoclonal antibody alone, recombinant ricin A chain alone, or an irrelevant immunotoxin, MOP21C monoclonal antibody-recombinant ricin A, did not diminish the number of cells. There was a marked decrease in DNA synthesis measured by nuclear tritiated thymidine incorporation that accompanied the immunotoxin-mediated decrease in cell number. Viable cells remaining after exposure to the immunotoxin (0.1 to 10 000 ng/mL) were morphologically abnormal; typically the cells had elongated spindle-shaped processes and had lost their normal cuboidal appearance. In contrast, cell number was not decreased in confluent human retinal pigment epithelial cells after treatment with maximal doses of immunotoxin. Morphologic changes similar to those seen in proliferating cells were observed in confluent cells exposed to more than 100 ng/mL of immunotoxin. The effect of the immunotoxin was species specific because large doses of immunotoxin did not reduce the number of viable cells in proliferating or confluent pig retinal pigment epithelial cells or cause observable morphologic changes in this cell type. Our results indicate that the immunotoxin selectively inhibited proliferating retinal pigment epithelial cells by receptor-mediated internalization of the antitransferrin receptor monoclonal antibody-recombinant ricin A chain conjugate.

References
1.
Glaser BM, Lemor M.  Pathobiology of proliferative vitreoretinopathy . In: Ryan SJ, ed. Retina . St Louis, Mo: CV Mosby Co; 1989:3:369-383.
2.
Blumenkranz MS, Hartzer MK.  The mechanism of action of drugs for the treatment of vitreoretinal scarring . In: Ryan SJ, ed. Retina . St Louis, Mo: CV Mosby Co; 1989;3:401-411.
3.
Peyman GA, Schulman J.  Proliferative vitreoretinopathy and chemotherapeutic agents . Surv Ophthalmol . 1985;29:434-442.Article
4.
Endo Y, Mitsui K, Motizuki M, Tsurugi K.  Mechanisms of action of the toxin lectin ricin on eukaryotic 28S ribosomes: the site and characteristics of modification in rRNA caused by the toxin . J Biol Chem . 1987;262:5908-5912.
5.
Seligman PA.  Structure and function of the transferrin receptor . Prog Hematol . 1983;13:131-147.
6.
Frazier JL, Caskey JH, Yoffe M, Seligman PA.  Studies of the transferrin receptor on both human reticulocytes and nucleated human cells in culture: comparison of factors regulating receptor density . J Clin Invest . 1982;69:853-865.Article
7.
Chitambar CR, Massey EJ, Seligman PA.  Regulation of transferrin receptor expression on human leukemic cells during proliferation and induction of differentiation: effects of gallium and dimethylsulfoxide . J Clin Invest . 1983;72:1314-1325.Article
8.
Omary MB, Trowbridge IS, Minowada J.  Human cell-surface glycoprotein with unusual properties . Nature . 1980;286:881-891.Article
9.
Edwards RB.  Culture of mammalian retinal pigment epithelium and neural retina . Methods Enzymol . 1982;81:39-43.
10.
Song MK, Lui GM.  Propagation of human fetal RPE cells: preservation of original culture morphology after serial passage . J Cell Physiol . 1990;143:196-203.Article
11.
Frankel AE, Ring DB, Tringale F, Hsich-Ma ST.  Tissue distribution of breast cancer-associated antigens defined by monoclonal antibodies . J Biol Response Mod . 1985;4:273-286.
12.
Piatak M, Lane JA, Laird W, Bjorn MJ, Wang A, Williams M.  Expression of soluble and fully functional ricin A chain in Escherichia coli is temperature-sensitive . J Biol Chem . 1988;263:4837-4847.
13.
Fulcher S, Lui G, Houston LL, et al.  Use of immunotoxin to inhibit proliferating human corneal endothelium . Invest Ophthalmol Vis Sci . 1988;29:755-759.
14.
Jaffe GJ, Burke JM, Geroski DH.  Ouabainsensitive Na+ - K+ ATPase pumps in cultured human retinal pigment epithelium . Exp Eye Res . 1989;48:61-68.Article
15.
Olsnes S, Refsnes K, Pihl A.  Mechanism of action of the toxic lectins abrin and ricin . Nature . 1974;249:627-631.Article
16.
Trowbridge IS, Domingo DL.  Anti-transferrin receptor monoclonal antibody and toxin-antibody conjugates affect growth of human tumour cells . Nature . 1981;294:12:171-173.Article
17.
Raso V, Basala M.  A highly cytotoxic human transferrin-ricin A chain conjugate used to select receptor-modified cells . J Biol Chem . 1984;259:1143-1149.
18.
Vidaurri-Leal JS, Glaser BM.  Effect of fibrin on morphologic characteristics of retinal pigment epithelial cells . Arch Ophthalmol . 1984;102:1376-1379.Article
19.
Vidaurri-Leal JS, Hohman R, Glaser BM.  Effect of vitreous on morphologic characteristics of retinal pigment epithelial cells . Arch Ophthalmol . 1984;102:1220-1223.Article
20.
Blumenkranz M, Hernandez E, Ophir A, Norton EWD.  5-Fluorouracil: new applications in complicated retinal detachment for an established antimetabolite . Ophthalmology . 1984;91:122-130.Article
21.
Wiedemann P, Lemmen K, Schmiedl R, Heimann K.  Intraocular daunorubicin for the treatment and prophylaxis of traumatic proliferative vitreoretinopathy . Am J Ophthalmol . 1987;104:10-14.
22.
Stern WH, Heath TD.  Drug delivery systems for treatment of proliferative vitreoretinopathy . In: Ryan SJ, ed. Retina . St Louis, Mo: CV Mosby Co; 1989;3:413-418.
23.
Maurice DM.  Injection of drugs into the vitreous body . In: Leopold J, Burns R, eds. Symposium on Ocular Therapy . New York, NY: John Wiley & Sons Inc; 1976:59-72.
24.
Jaffe GJ, Green GDJ, McKay BS, Hartz A, Williams GA.  Intravitreal clearance of tissue plasminogen activator in the rabbit . Arch Ophthalmol . 1988;106:969-972.Article
25.
Williams GA, Lambrou FH, Jaffe GJ, et al.  Treatment of postvitrectomy fibrin formation with intraocular tissue plasminogen activator . Arch Ophthalmol . 1988;106:1055-1058.Article
26.
Weller M, Wiedemann P, Heimann K, Zilles K.  Macrophages, fibronectin, transferrin: major pathogenetic factors in proliferative vitreoretinopathy . In: Heimann K, Wiedemann P, eds. Proliferative Vitreoretinopathy . Heidelberg, Federal Republic of Germany: Kaden Verlag; 1989:104-108.
×